A 24-week multicentre, observational study to evaluate the efficacy, tolerability and efficacy of the combination of vildagliptin plus metformin in Turkish patients with type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2015
At a glance
- Drugs Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms GALATA
- 06 Dec 2013 New trial record
- 06 Nov 2013 Results presented at the 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.